The Malaysian Competition Commission has initiated a market review on the pharmaceutical sector. What does this mean for companies?
Chen Hong SzeBrowsing
Hong Sze Chen is a partner in the Intellectual Property Practice Group. She advises on IP, information technology and communications ("ITC"), data protection, competition, pharmaceuticals, consumer Ms. Chen represents clients on transactional IP matters and regularly advises clients on a wide range of commercial issues relating to IP assets; from corporate and IP due diligence, documentations, negotiations and licensing requirements to compliance obligations and registration procedures in obtaining regulatory approvals. She has been involved in assisting clients with ground-breaking work in IP valuation, and regularly advises on issues in corporate M&As and joint ventures involving the transfer of IP and/or technology assets.protection, franchising and advertising matters.